Arcutis Biotherapeutics, Inc. (ARQT)
24.79
-0.29
(-1.16%)
USD |
NASDAQ |
Aug 24, 16:00
24.79
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Total Liabilities (Quarterly) : 267.96M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 267.96M |
| March 31, 2026 | 270.36M |
| December 31, 2025 | 243.49M |
| September 30, 2025 | 212.90M |
| June 30, 2025 | 213.46M |
| March 31, 2025 | 201.45M |
| December 31, 2024 | 191.35M |
| September 30, 2024 | 280.71M |
| June 30, 2024 | 258.33M |
| March 31, 2024 | 253.60M |
| December 31, 2023 | 252.70M |
| September 30, 2023 | 246.24M |
| June 30, 2023 | 240.18M |
| March 31, 2023 | 239.73M |
| December 31, 2022 | 239.69M |
| September 30, 2022 | 238.14M |
| Date | Value |
|---|---|
| June 30, 2022 | 105.08M |
| March 31, 2022 | 110.34M |
| December 31, 2021 | 110.48M |
| September 30, 2021 | 24.01M |
| June 30, 2021 | 18.40M |
| March 31, 2021 | 20.42M |
| December 31, 2020 | 27.65M |
| September 30, 2020 | 24.94M |
| June 30, 2020 | 23.05M |
| March 31, 2020 | 12.51M |
| December 31, 2019 | 5.55M |
| September 30, 2019 | 9.001M |
| June 30, 2019 | 4.585M |
| March 31, 2019 | |
| December 31, 2018 | 2.833M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Insmed, Inc. | 1.345B |
| Emergent BioSolutions, Inc. | 775.40M |
| Exelixis, Inc. | 650.47M |
| Vertex Pharmaceuticals, Inc. | 7.175B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 488.54M |
| Shareholders Equity (Quarterly) | 220.58M |
| Debt to Equity Ratio | 0.5174 |
| Current Ratio | 2.917 |
| Net Debt Paydown Yield | -0.02% |